Go

Breaking News on Pharmaceutical Technology

All feeds

News headlines > Materials & Formulation

Text size Print Email this page

News in brief

RFCL’s Mallinckrodt take over now uncertain?

01-Dec-2008

Related topics: Materials & Formulation, Ingredients, excipients and raw materials

Economic uncertainty may have scuppered Ranbaxy Fine Chemicals’ efforts to buy US chemicals rival Mallinckrodt Baker, according to a report in India’s Economic Times.

RFCL financial backer I Ventures, which had valued Mallinckrodt at between $325-$350m, is understood to be revising this figure due to a weaker than expected third quarter at the US firm and the difficult global economic climate.

The entire global financial markets have changed since September. Hence, it’s only logical that the deal needs revaluation,” according to an unnamed industry source quoted by the Times. The source also raises doubts about the ease of attracting private equity during the global slump

Related Products, Brochures, Web links

Product presentations